These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12148385)

  • 1. [Update on the use of levofloxacin in the management of acute exacerbations of chronic bronchitis with risk factors].
    Zuck P
    Presse Med; 2002 Jun; 31(21 Pt 2):S15-8. PubMed ID: 12148385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal treatment strategies for acute exacerbations of chronic bronchitis: high-risk patients.
    Norrby SR
    Chemotherapy; 2001; 47 Suppl 4():47-52; discussion 53-4. PubMed ID: 11586005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
    Scheen AJ
    Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Workplace costs associated with acute exacerbation of chronic bronchitis: a comparison of moxifloxacin and levofloxacin.
    Li-McLeod J; Perfetto EM
    Manag Care Interface; 2001 Feb; 14(2):52-9. PubMed ID: 11228817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic bronchitis. What antibiotic in acute exacerbations. Good and fast effectiveness is needed].
    MMW Fortschr Med; 2002 Feb; 144(7):66-7. PubMed ID: 11887739
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of levofloxacin in the treatment of acute exacerbation of chronic bronchitis in patients with risk factors].
    Zuck P; Veyssier P; Brumpt I
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 1):269-77. PubMed ID: 15687910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical contribution of the newer fluoroquinolones in acute bacterial exacerbation of chronic bronchitis].
    Niederman MS
    Medicina (B Aires); 1999; 59 Suppl 1():23-30. PubMed ID: 10436551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis.
    Cazzola M; Matera MG; Donnarumma G; Tufano MA; Sanduzzi A; Marchetti F; Blasi F
    Chest; 2005 Oct; 128(4):2093-8. PubMed ID: 16236860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
    Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.
    Anzueto A; Miravitlles M; Ewig S; Legnani D; Heldner S; Stauch K
    Respir Med; 2012 Sep; 106(9):1258-67. PubMed ID: 22749710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
    Masterton RG; Burley CJ
    Int J Antimicrob Agents; 2001 Dec; 18(6):503-12. PubMed ID: 11738336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
    Ruiz-González A; Giménez A; Gómez-Arbonés X; Soler-González J; Sánchez V; Falguera M; Porcel JM
    Respirology; 2007 Jan; 12(1):117-21. PubMed ID: 17207036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of antibiotics in chronic bronchitis].
    Guseĭnov KhIu
    Probl Tuberk; 2000; (1):23-4. PubMed ID: 10750424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis.
    Nicolau DP; Sutherland C; Winget D; Baughman RP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):94-8. PubMed ID: 22210007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of levofloxacin in the hospital].
    Castells X; Vallano A; Campany D; Rigau D; Arnau JM
    Rev Esp Quimioter; 2003 Jun; 16(2):221-6. PubMed ID: 12973461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is co-morbidity taken into account in the antibiotic management of elderly patients with acute bronchitis and COPD exacerbations?
    Bont J; Hak E; Birkhoff CE; Hoes AW; Verheij TJ
    Fam Pract; 2007 Sep; 24(4):317-22. PubMed ID: 17602175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin in patients with severe respiratory tract infection.
    Odagiri S
    Drugs; 1995; 49 Suppl 2():426-7. PubMed ID: 8549387
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
    Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
    Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ofloxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbation of chronic bronchitis. Study of Ofloxacin in Lower Respiratory Tract Infections Research Group.
    Pérez-Gonzalvo ME; Mosquera-Pestaña JA; Ramos D; Apilánez J; Borja J; Arnau C; García-Barbal J; Marín-Pardo J
    Clin Ther; 1996; 18(3):440-7. PubMed ID: 8829019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.